Literature DB >> 22138326

The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects.

Mei Yang1, Vasish Kavi, Wenfu Wang, Zhimei Wu, Wei Hao.   

Abstract

OBJECTIVE: To explore the association between the 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR polymorphisms with comorbidity of antisocial personality disorder in male heroin-dependent patients. SUBJECTS AND METHODS: In case control study, we compared the polymorphic distributions of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR in 588 male heroin-dependent patients (including 311 patients with antisocial personality disorder and 277 patients without antisocial personality disorder) and 194 normal males by genotypes, alleles, and interaction between genes.
RESULTS: Between male heroin-dependent patients with antisocial personality disorder and normal males, and between male heroin-dependent patients with and without antisocial personality disorder, the distributions of 5-HTTVNTR polymorphic genotypes and alleles were in statistical significance. Individuals carrying 10R allele were in higher risk of the comorbidity of antisocial personality disorder and heroin dependence. By MDR analyses, the interaction between 5-HTTVNTR and DATVNTR was close to statistical significance in predicting the risk of antisocial personality disorder in male heroin dependent patients. In male heroin dependent patients, individuals carrying 5-HTTVNTR 10R allele or/and DATVNTR 9R allele were in higher risks of co-occurring antisocial personality disorder, while individuals with 5-HTTVNTR 12R/12R and DATVNTR 10R/10R genotypes together were in lower risks of antisocial personality disorder.
CONCLUSION: 5-HTTVNTR, and the interaction between 5-HTTVNTR and DATVNTR may be associated with the comorbidity of antisocial personality disorder in male heroin-dependent patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138326     DOI: 10.1016/j.pnpbp.2011.11.009

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  8 in total

1.  Association of the HTR2A gene with alcohol and heroin abuse.

Authors:  Jian Cao; Xiangtao Liu; Shizhong Han; Clarence K Zhang; Zongzhi Liu; Dawei Li
Journal:  Hum Genet       Date:  2013-11-01       Impact factor: 4.132

2.  Association of dopamine receptor gene polymorphism and psychological personality traits in liability for opioid addiction.

Authors:  Nermana Mehić-Basara; Lilijana Oruč; Lejla Kapur-Pojskić; Jasmin Ramić
Journal:  Bosn J Basic Med Sci       Date:  2013-08       Impact factor: 3.363

Review 3.  Genetic and Neuroimaging Features of Personality Disorders: State of the Art.

Authors:  Guorong Ma; Hongying Fan; Chanchan Shen; Wei Wang
Journal:  Neurosci Bull       Date:  2016-04-01       Impact factor: 5.203

4.  Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder.

Authors:  Jian Cao; James J Hudziak; Dawei Li
Journal:  Neuropsychopharmacology       Date:  2013-03-21       Impact factor: 7.853

Review 5.  Monoamine Oxidase A in Antisocial Personality Disorder and Borderline Personality Disorder.

Authors:  Nathan J Kolla; Sarah A Vinette
Journal:  Curr Behav Neurosci Rep       Date:  2017-02-03

6.  Serum proteomic analysis reveals high frequency of haptoglobin deficiency and elevated thyroxine level in heroin addicts.

Authors:  Bing-Ying Zhou; Shi-Yan Yan; Wan-Lu Shi; Zhi Qu; Xin Zhao; Zhi-Min Liu; Xiao-Ping Pu
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

7.  Association between serotonin transporter gene polymorphisms and heroin dependence: a meta-analytic study.

Authors:  Pao-Yen Lin; Yi-Shan Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-30       Impact factor: 2.570

8.  Polymorphism of serotonin transporter gene in male subjects with antisocial behavior and MMA fighters.

Authors:  Elena V Cherepkova; Vladimir V Maksimov; Lyubomir I Aftanas
Journal:  Transl Psychiatry       Date:  2018-11-15       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.